Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -41.71EBITDA per Share
VS
Market
Sector
Industry
History
$ 9.25Close
$ 5.09 - $ 94.02 52-Week Range
Ticker Information
Ticker
CNSPCompany Name
CNS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCNS PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CNSP - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -15.44M | $ -41.71 | 1 | 370.13K |
| 3/31/2025 | $ -15.6M | $ -68.63 | 1 | 227.22K |
| 12/31/2024 | $ -14.84M | $ -465.84 | 1 | 31.85K |
| 9/30/2024 | $ -17.04M | $ -460.86 | 1 | 36.97K |
| 6/30/2024 | $ -15.95M | $ -25.4K | 1 | 628 |
| 3/31/2024 | $ -17.45M | $ -60.16K | 1 | 290 |
| 12/31/2023 | $ -18.83M | $ -149.47K | 1 | 126 |
| 9/30/2023 | $ -18.96M | $ -136.41K | 1 | 139 |
| 6/30/2023 | $ -17.86M | $ -138.43K | 1 | 129 |
| 3/31/2023 | $ -17.4M | $ -271.91K | 1 | 64 |
Key Performance Insights, Last 5 Years
- CNS PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -498.2K.
- Over the past 5 years, CNS PHARMACEUTICALS INC's average EBITDAPS has been $ -242.1K.
- The median EBITDAPS for CNS PHARMACEUTICALS INC during this period was $ -278.51K
- CNS PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ -41.71.
- The lowest EBITDAPS recorded by CNS PHARMACEUTICALS INC in the same timeframe $ -524.64K
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for CNS PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -8.97M ] / (Shares WA [ 18 ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -498.2K ] CNSP - EBITDA per Share, Last 5 years
$ -524.64K
Minimum
Dec 31, 2020
$ -41.71
Maximum
Jun 30, 2025
$ -242.1K
Average
$ -278.51K
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |